
Amid a threat of towering US tariffs, Swiss pharmaceutical giant Novartis is seeking ways to enable Americans to pay less for their medicines, its chief said in an interview published Saturday.
Vasant Narasimhan told the Swiss daily Neue Zurcher Zeitung (NZZ) that his company was "working to eliminate the price gap between the US and other industrialised countries".